Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
52,406,487
-
Total 13F shares
-
18,695,153
-
Share change
-
+18,695,153
-
Total reported value
-
$479,312,107
-
Put/Call ratio
-
36%
-
Price per share
-
$25.63
-
Number of holders
-
108
-
Value change
-
+$479,312,107
-
Number of buys
-
108
Institutional Holders of 2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) as of Q4 2021
As of 31 Dec 2021,
2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,695,153 shares.
The largest 10 holders included
STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, EcoR1 Capital, LLC, VANGUARD GROUP INC, BlackRock Inc., ARMISTICE CAPITAL, LLC, CREDIT SUISSE AG/, BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P., and GOLDMAN SACHS GROUP INC.
This page lists
108
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.